Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3637619010 | Acalabrutinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3637620016 | Acalabrutinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acalabrutinib | est un(e) (attribut) | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Acalabrutinib | est un(e) (attribut) | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Acalabrutinib | est un(e) (attribut) | Benzimidazole (substance) | true | Inferred relationship | Some | ||
| Acalabrutinib | Has disposition (attribute) | Non-specific protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Acalabrutinib | est un(e) (attribut) | Non-specific protein-tyrosine kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acalabrutinib only product | a pour principe actif (attribut) | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Acalabrutinib only product in oral dose form | a pour principe actif (attribut) | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Product containing acalabrutinib (medicinal product) | a pour principe actif (attribut) | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Acalabrutinib-containing product in oral dose form | a pour principe actif (attribut) | True | Acalabrutinib | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR